rd - United States News Beep

#EASD26: Lilly’s amylin-Zepbound combo posts best-ever weight loss in patients with obesity and diabetes Endpoints NewsWhy Lilly and Novo…

Roche has scrapped development of a muscle-building drug, ending a trial testing the experimental medicine in combination with…

“From 2021 through 2025 alone, Bayh-Dole-enabled tech transfer generated up to $288 billion in U.S. GDP, $577 billion…

Almost three years into his tenure as Lundbeck’s CEO, Charl van Zyl is confident the company can prove…

ANKARA Türkiye’s budget allocations for R&D for space exploration activities rise from 13.2 billion Turkish Liras to 309…

Science Corporate, university expenditures for 2024 include computers, electronics China’s jump in R&D spending was driven by corporate…

MONTREAL — After Novo Nordisk closed its cell therapy unit, Cellular Intelligence contracted neurologist and drug developer Nuno…

Retraction of high-profile paper on cancer drug timing could hand ammo to China hawks Endpoints NewsNature retracts provocative PD-1…

Compass Pathways soars as psilocybin depression treatment hits second Phase 3 trial goals Endpoints NewsCompass Pathways to Announce New…

Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRoche unveils data behind BTK inhibitor’s phase 3…

Lawrence J. Lau is a Hong Kong economist specialising in economic development and East Asian economies. He was…

Exclusive: In major test for longevity field, FDA greenlights study on a ‘near total reset’ of cells Endpoints NewsScientists…

rd